Research
Title : | Harnessing therapeutic potential of novel Spisulosine derivative as robust autophagy inducer against Triple Negative Breast Cancer (TNBC) in-vitro & in-vivo |
Area of research : | Medical Sciences |
Focus area : | Ad-hoc, ADHOC |
Principal Investigator : | Dr. D. Datta, CSIR-Central Drug Research Institute, Uttar Pradesh |
Timeline Start Year : | 2019 |
Timeline End Year : | 2022 |
Details
Total Budget (INR): | 16,60,000 |
Organizations involved
Implementing Agency : | CSIR-Central Drug Research Institute, Uttar Pradesh |
Funding Agency : | Indian Council of Medical Research (ICMR) |